Characteristics and Prognostic Implications in Newly Diagnosed KMT2Ar AML: A Multicenter Study of the ECLA Group.

Saved in:
Bibliographic Details
Title: Characteristics and Prognostic Implications in Newly Diagnosed KMT2Ar AML: A Multicenter Study of the ECLA Group.
Authors: Pan J; Department of Hematology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.; Zhejiang Provincial Key Lab of Hematopoietic Malignancy, Zhejiang University, Hangzhou, China.; Zhejiang Provincial Clinical Research Center for Hematological Disorders, Hangzhou, China.; Zhejiang University Cancer Center, Hangzhou, China., Fu C; National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, the First Affiliated Hospital of Soochow University, Suzhou, China.; Department of Hematology, Xuzhou Central Hospital, Southeast University, Xuzhou, China., Ling Q; Department of Hematology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.; Zhejiang Provincial Key Lab of Hematopoietic Malignancy, Zhejiang University, Hangzhou, China.; Zhejiang Provincial Clinical Research Center for Hematological Disorders, Hangzhou, China.; Zhejiang University Cancer Center, Hangzhou, China., Lu Y; Department of Hematology, The Affiliated People's Hospital of Ningbo University, Ningbo, China., Shi Y; Department of Hematology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China., Zhang Y; Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine at Shanghai, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China., Wang S; Department of Hematology, Fujian Institute of Hematology, Fujian Provincial Key Laboratory on Hematology, Fujian Medical University Union Hospital, Fuzhou, China., Ji C; Department of Hematology, Qilu Hospital of Shandong University, Jinan, China., Qian S; Department of Hematology, Affiliated Hangzhou First People's Hospital, School of Medicine, Westlake University, Hangzhou, China., Huang Z; Department of Hematology, The First Affiliated Hospital of Anhui Medical University, Hefei, China., Ge Z; Department of Hematology, Zhongda Hospital, School of Medicine, Southeast University, Institute of Hematology, Southeast University, Nanjing, China., Zhang J; Department of Hematology, Affiliated Jinhua Hospital, Zhejiang University School of Medicine, Jinhua, China., Ouyang G; Department of Hematology, The First Affiliated Hospital of Ningbo University, Ningbo, China., Jin C; Jiangxi Provincial People's Hospital, the First Affiliated Hospital of Nanchang Medical College, Nanchang, China., Lu Q; Department of Hematology, Zhongshan Hospital of Xiamen University, Xiamen, China., Huang L; Department of Hematology, The Affiliated Jinhua Hospital of Wenzhou Medical University, Jinhua, China., Kong H; Department of Hematology, People's Hospital of Quzhou City, Quzhou, China., Zhu Y; Department of Hematology, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing, China., Yan Z; Department of Hematology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, China., Liu D; Department of Hematology, Quanzhou First Hospital, Fujian Medical University, Quanzhou, China., Jiang H; Department of Hematology, The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China., Chen N; Department of Hematology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.; Zhejiang Provincial Key Lab of Hematopoietic Malignancy, Zhejiang University, Hangzhou, China.; Zhejiang Provincial Clinical Research Center for Hematological Disorders, Hangzhou, China.; Zhejiang University Cancer Center, Hangzhou, China., Lin X; Department of Hematology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.; Zhejiang Provincial Key Lab of Hematopoietic Malignancy, Zhejiang University, Hangzhou, China.; Zhejiang Provincial Clinical Research Center for Hematological Disorders, Hangzhou, China.; Zhejiang University Cancer Center, Hangzhou, China., Zhou Y; Department of Hematology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.; Zhejiang Provincial Key Lab of Hematopoietic Malignancy, Zhejiang University, Hangzhou, China.; Zhejiang Provincial Clinical Research Center for Hematological Disorders, Hangzhou, China.; Zhejiang University Cancer Center, Hangzhou, China., Zhang Y; Department of Hematology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.; Zhejiang Provincial Key Lab of Hematopoietic Malignancy, Zhejiang University, Hangzhou, China.; Zhejiang Provincial Clinical Research Center for Hematological Disorders, Hangzhou, China.; Zhejiang University Cancer Center, Hangzhou, China., Li X; Department of Hematology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.; Zhejiang Provincial Key Lab of Hematopoietic Malignancy, Zhejiang University, Hangzhou, China.; Zhejiang Provincial Clinical Research Center for Hematological Disorders, Hangzhou, China.; Zhejiang University Cancer Center, Hangzhou, China., Tong H; Department of Hematology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.; Zhejiang Provincial Key Lab of Hematopoietic Malignancy, Zhejiang University, Hangzhou, China.; Zhejiang Provincial Clinical Research Center for Hematological Disorders, Hangzhou, China.; Zhejiang University Cancer Center, Hangzhou, China., Jin J; Department of Hematology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.; Zhejiang Provincial Key Lab of Hematopoietic Malignancy, Zhejiang University, Hangzhou, China.; Zhejiang Provincial Clinical Research Center for Hematological Disorders, Hangzhou, China.; Zhejiang University Cancer Center, Hangzhou, China., Chen S; National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, the First Affiliated Hospital of Soochow University, Suzhou, China.; Institute of Blood and Marrow Transplantation, Collaborative Innovation Center of Hematology, Soochow University, Suzhou, China., Wang H; Department of Hematology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.; Zhejiang Provincial Key Lab of Hematopoietic Malignancy, Zhejiang University, Hangzhou, China.; Zhejiang Provincial Clinical Research Center for Hematological Disorders, Hangzhou, China.; Zhejiang University Cancer Center, Hangzhou, China.
Corporate Authors: East China Leukemia Alliance
Source: American journal of hematology [Am J Hematol] 2026 Aug; Vol. 101 (8), pp. 1938-1953. Date of Electronic Publication: 2026 May 26.
Publication Type: Journal Article; Multicenter Study
Journal Info: Publisher: Wiley-Blackwell Country of Publication: United States NLM ID: 7610369 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1096-8652 (Electronic) Linking ISSN: 03618609 NLM ISO Abbreviation: Am J Hematol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1096-8652
DOI:10.1002/ajh.70377